4-Bromo-3,5-dichloropyridin-2-amine, 98%, 100mg

1,5-Dimethyl-3-nitro-1H-pyrazole, 250mg

2-(3-Aminobicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride, 98%, 250mg

2,4-diamino-6-hydroxy-5-pyrimidinecarbaldehyde hydrate, 95.0%, 25g

(11bS)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 99.93%, 100mg

3-Bromo-2-chloro-5-nitropyridin-4-amine, 95%, 5g

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 150, 500 ml, 120 mm, 1 Piece

8-Amino-4-Boc-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 1g

2,5-Dibromocyclohexa-2,5-diene-1,4-dione, 98%, 100mg

4-Amino-3-fluorophenol>98.0%(GC)(T)1g

2-(2-mercapto-6-oxo-1,6-dihydropyrimidin-4-yl)-N-methylacetamide, 95.0%, 250mg

2-(pyridin-2-yloxy)benzonitrile, 95.0%, 500mg

2-Cyclopentyl-L-glycine, 97.0%, 1g